alignment healthcare inc - ALHC
ALHC
Close Chg Chg %
8.43 -0.37 -4.39%
Closed Market
8.06
-0.37 (4.39%)
Volume: 5.17M
Last Updated:
Oct 23, 2026, 4:00 PM EDT
Company Overview: alignment healthcare inc - ALHC
ALHC Key Data
| Open $8.36 | Day Range 7.91 - 8.37 |
| 52 Week Range 6.01 - 25.12 | Market Cap $1.75B |
| Shares Outstanding 207.44M | Public Float 198.39M |
| Beta 1.14 | Rev. Per Employee N/A |
| P/E Ratio 45.21 | EPS $0.20 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 9.15M |
ALHC Performance
| 1 Week | -2.66% | ||
| 1 Month | -1.83% | ||
| 3 Months | -58.52% | ||
| 1 Year | -53.97% | ||
| 5 Years | -59.42% |
ALHC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
15
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 13.308 | |
| Number of Ratings | 15 | Current Quarters Estimate | -0.049 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 0.141 | |
| Last Quarter’s Earnings | -0.03 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | N/A | Next Fiscal Year Estimate | 0.317 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 8 | 11 | 11 |
| Mean Estimate | -0.05 | 0.08 | 0.14 | 0.32 |
| High Estimates | -0.02 | 0.14 | 0.19 | 0.52 |
| Low Estimate | -0.08 | 0.02 | 0.09 | 0.19 |
| Coefficient of Variance | -45.05 | 48.26 | 24.40 | 32.52 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 10 | 10 |
| OVERWEIGHT | 3 | 2 | 2 |
| HOLD | 4 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Buy | Buy |
SEC Filings for Alignment Healthcare Inc - ALHC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Alignment Healthcare Inc - ALHC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Hyong J. Kim Chief Medical Officer | 299,271 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $8.3 per share | 2,483,949.30 |
| Jun 19, 2026 | Joseph S. Konowiecki EVP, Corporate Affairs; Director | 1,153,816 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22 per share | 25,383,952.00 |
| Apr 16, 2026 | Dawn C. Maroney President | 1,028,813 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $20.87 per share | 21,471,327.31 |